| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/14/2022 | Corvus Pharmaceuticals, Inc. | CRVS | Purchase | Common Stock | 4k | $0.84 | $3.4k | By IRA | 12/13/2022 |
| 12/13/2022 | Corvus Pharmaceuticals, Inc. | CRVS | Purchase | Common Stock | 30k | $0.74 | $22.3k | By IRA | 12/13/2022 |
| 08/11/2022 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 160k | $0.97 | $154.4k | | 08/11/2022 |
| 03/17/2022 | Corvus Pharmaceuticals, Inc. | CRVS | Purchase | Common Stock | 13.9k | $1.65 | $22.9k | By IRA | 03/16/2022 |
| 03/16/2022 | Corvus Pharmaceuticals, Inc. | CRVS | Purchase | Common Stock | 35.2k | $1.54 | $54.1k | By IRA | 03/16/2022 |
| 09/09/2021 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 160k | $2.60 | $416k | | 09/09/2021 |
| 12/16/2020 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 160k | $4.01 | $641.6k | | 12/16/2020 |
| 12/12/2019 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 160k | $3.54 | $566.4k | | 12/12/2019 |
| 06/07/2019 | Corvus Pharmaceuticals, Inc. | CRVS | Purchase | Common Stock, $0.0001 par value | 10k | $3.38 | $33.8k | By IRA | 06/06/2019 |
| 06/06/2019 | Corvus Pharmaceuticals, Inc. | CRVS | Purchase | Common Stock, $0.0001 par value | 15.5k | $3.56 | $55.2k | By IRA | 06/06/2019 |
| 12/21/2018 | Corvus Pharmaceuticals, Inc. | CRVS | Purchase | Common Stock, $0.0001 par value | 24.7k | $4.15 | $102.4k | By IRA | 12/21/2018 |
| 12/12/2018 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 100k | $5.94 | $594k | | 12/12/2018 |
| 12/13/2017 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 40k | $10.60 | $424k | | 12/13/2017 |